Document:

sbbp_Ex_1016

		
			Exhibit 10.16
		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			2015 EQUITY COMPENSATION PLAN
		

		
			INCENTIVE STOCK OPTION AWARD
		

		
			Strongbridge Biopharma plc (the “Company”) has granted you an Incentive Stock Option (the “Option”) under the 2015 Equity Compensation Plan (the “Plan”).  The terms of the grant are set forth in the Incentive Stock Option Award Agreement provided to you (the “Agreement”).  The following provides a summary of the key terms of the grant; however, you should read the entire Agreement, along with the terms of the Plan, to fully understand the grant.
		

		
			 
		

		
			SUMMARY OF INCENTIVE STOCK OPTION AWARD
		

		
			 
		

			
					
						Grantee:

					
					
						______________________________

				
	
					
						Date of Grant:

					
					
						

				
	
					
						Vesting Schedule:

					
					
						______________________________

				
	
					
						Exercise Price Per Share:

					
					
						   

				
	
					
						Total Number of Options Granted:

					
					
						

				
	
					
						Term/Expiration Date:

					
					
						

				

		
			
		

		
			

		 

		

			

		

 

		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			2015 EQUITY COMPENSATION PLAN
		

		
			INCENTIVE STOCK OPTION AWARD AGREEMENT
		

		
			This INCENTIVE STOCK OPTION AWARD AGREEMENT (the “Agreement”), dated as of [_________________] (the “Date of Grant”), is delivered by Strongbridge Biopharma plc (the “Company”) to [_____________________] (the “Grantee”).
		

		
			RECITALS
		

		
			A.The 2015 Equity Compensation Plan (the “Plan”) provides for the grant of options to purchase shares of common stock of the Company (“Company Stock”).  The Company has decided to make a stock option award as an inducement for the Grantee to promote the best interests of the Company and its stockholders. Capitalized terms that are used but not defined herein shall have the respective meanings accorded to such terms in the Plan.  
		

		
			B.The Plan is administered and interpreted by the Compensation Committee of the Board of Directors of the Company (the “Board”) (or a subcommittee thereof), or such other committee of the Board (including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions of the Plan (the “Committee”). The Committee may delegate authority to one or more subcommittees as it deems appropriate.  If a subcommittee is appointed, all references in this Agreement to the “Committee” shall be deemed to refer to the committee.
		

		
			NOW, THEREFORE, the parties to this Agreement, intending to be legally bound hereby, agree as follows:
		

			
	
			
				 1.
			Grant of Option.  Subject to the terms and conditions set forth in this Agreement and in the Plan, the Company hereby grants to the Grantee an Incentive Stock Option (the “Option”) to purchase ___________ shares of Company Stock at an exercise price of $[____] per share.

			
	
			
				 2.
			Vesting.  The Option shall become vested and exercisable, according to the vesting schedule set forth on Attachment A, if the Grantee continues to be employed by, or provide service to, the Company (or its parent or subsidiary, as applicable) (the “Employer”) from the Date of Grant until the applicable vesting date.

			
	
			
				 3.
			Term of Option.

			
	
			
				 (a)
			The Option shall have a term of ten (10) years from the Date of Grant and shall terminate at the expiration of that period, unless it is terminated at an earlier date pursuant to the provisions of this Agreement or the Plan.

			
	
			
				 (b)
			Unless a later termination date is provided for in a Company-sponsored plan, policy or arrangement, or any agreement to which the Employer is a party, the Option shall automatically terminate upon the happening of the first of the following events:

		
			

		 

		

			-  1  -

		

 

		

			
	
			
				 (i)
			The expiration of the ninety (90) day period after the Grantee ceases to be employed by, or provide service to, the Employer, if the termination is for any reason other than Disability (as defined in the Plan), death or Cause (as defined in the Plan).

			
	
			
				 (ii)
			The expiration of the one (1) year period after the Grantee ceases to be employed by, or provide service to, the Employer on account of the Grantee’s Disability.

			
	
			
				 (iii)
			The expiration of the one (1) year period after the Grantee ceases to be employed by, or provide service to, the Employer, if the Grantee dies (x) while employed by, or providing service to, the Employer or (y) within ninety (90) days after the Grantee ceases to be so employed or provide such services on account of a termination described in subparagraph (i) above.

			
	
			
				 (iv)
			The date on which the Grantee ceases to be employed by, or provide service to, the Employer on account of a termination by the Employer for Cause.  In addition, notwithstanding the prior provisions of this Paragraph 3, if the Board determines that the Grantee has engaged in conduct that constitutes Cause at any time while the Grantee is employed by, or providing service to, the Employer or after the Grantee’s termination of employment or service, any Option held by the Grantee shall immediately terminate, and the Grantee shall automatically forfeit all shares underlying any exercised portion of an Option for which the Company has not yet delivered the share certificates, upon refund by the Company of the Exercise Price paid by the Grantee for such shares.

		
			Notwithstanding the foregoing, in no event may the Option be exercised after the date that is immediately before the tenth anniversary of the Date of Grant.  Any portion of the Option that is not vested and exercisable at the time the Grantee ceases to be employed by, or provide service to, the Employer shall immediately terminate.
		

		
			 
		

			
	
			
				 4.
			Exercise Procedures

			
	
			
				 (a)
			Subject to the provisions of Paragraphs 2 and 3 above, the Grantee may exercise part or all of the vested Option by delivering a written notice of exercise to the Company in the manner provided in this Agreement, specifying the number of shares of Company Stock as to which the Option is to be exercised.  The Grantee shall pay the Exercise Price (i) in cash, (ii) by delivering shares of Company Stock owned by the Grantee (including Company Stock acquired in connection with the exercise of an Option, subject to such restrictions as the Committee deems appropriate) and having a Fair Market Value on the date of exercise equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares of Company Stock having a Fair Market Value on the date of exercise equal to the Exercise Price; (iii) by payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board; or (iv) by such other method as the Committee may approve.  In addition, the Grantee may elect to settle the Option on a “net basis” by taking delivery of the number of Company Stock equal to Fair Market Value of the shares subject to any Option less the exercise price, any tax (or governmental obligation) or other administration fees due. The Company may impose from time to time such limitations as it deems appropriate on the use of shares of Company Stock to exercise the Option.  

		
			

		 

		

			-  2  -

		

 

		

			
	
			
				 (b)
			The obligation of the Company to deliver shares of Company Stock upon exercise of the Option shall be subject to all applicable laws, rules, and regulations and such approvals by governmental agencies as may be deemed appropriate by the Company, including such actions as Company counsel shall deem necessary or appropriate to comply with relevant securities laws and regulations.  The Company may require that the Grantee (or other person exercising the Option after the Grantee’s death) represent that the Grantee is purchasing shares of Company Stock for the Grantee’s own account and not with a view to or for sale in connection with any distribution of the shares of Company Stock, or such other representation as the Company deems appropriate.  

			
	
			
				 (c)
			All obligations of the Company under this Agreement shall be subject to the rights of the Company as set forth in the Plan to withhold amounts required to be withheld for any taxes, if applicable.  The Grantee may elect to satisfy any tax withholding obligation of the Company with respect to the Option by having shares of Company Stock withheld up to an amount that does not exceed the minimum applicable withholding tax rate for federal (including FICA), state and local tax liabilities.

			
	
			
				 5.
			Designation as Incentive Stock Option.

			
	
			
				 (a)
			This Option is designated an incentive stock option under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”).  If the aggregate fair market value of the stock on the date of the grant with respect to which incentive stock options are exercisable for the first time by the Grantee during any calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds one hundred thousand dollars ($100,000), then the Option, as to the excess, shall be treated as a nonqualified stock option that does not meet the requirements of Section 422.  If and to the extent that the Option fails to qualify as an incentive stock option under the Code, the Option shall remain outstanding according to its terms as a nonqualified stock option.

			
	
			
				 (b)
			The Grantee understands that favorable incentive stock option tax treatment is available only if the Option is exercised while the Grantee is an employee of the Employer or within a period of time specified in the Code after the Grantee ceases to be an employee.  The Grantee understands that the Grantee is responsible for the income tax consequences of the Option, and, among other tax consequences, the Grantee understands that he or she may be subject to the alternative minimum tax under the Code in the year in which the Option is exercised.  The Grantee will consult with his or her tax adviser regarding the tax consequences of the Option.

			
	
			
				 (c)
			The Grantee agrees that the Grantee shall immediately notify the Company in writing if the Grantee sells or otherwise disposes of any Shares acquired upon the exercise of the Option and such sale or other disposition occurs on or before the later of (i) two (2) years after the Date of Grant or (ii) one (1) year after the exercise of the Option.  The Grantee also agrees to provide the Company with any information requested by the Company with respect to such sale or other disposition.

			
	
			
				 6.
			Change of Control.  Upon a Change of Control (as defined in the Plan), the Option shall automatically accelerate and become fully vested and exercisable, provided that the Grantee is employed by, or providing service to, the Employer on the date of such Change of Control. 

		
			

		 

		

			-  3  -

		

 

		

			
	
			
				 7.
			Restrictions on Exercise.  Except as the Company may otherwise permit pursuant to the Plan, only the Grantee may exercise rights under the Option during the Grantee’s lifetime and, after the Grantee’s death, the Option shall be exercisable (subject to the limitations specified in the Plan) solely by the personal representative or other person entitled to succeed to the rights of the Grantee, or by the person who acquires the right to exercise the Option by will or by the laws of descent and distribution, to the extent that the Option is vested and exercisable pursuant to this Agreement. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Option under the Grantee’s will or under the applicable laws of descent and distribution.

			
	
			
				 8.
			Adjustments.  The provisions of the Plan applicable to Adjustments (as described in Section 3 of the Plan) shall apply to the Option.

			
	
			
				 9.
			Grant Subject to Plan Provisions.  This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and in all respects shall be interpreted in accordance with the Plan.  The grant and exercise of the Option are subject to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (i) rights and obligations with respect to withholding taxes, (ii) the registration, qualification or listing of the shares of Company Stock, (iii) changes in capitalization of the Company and (iv) other requirements of applicable law.  The Committee shall have the authority to interpret and construe the Option pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.

			
	
			
				 10.
			No Employment or Other Rights.  The grant of the Option shall not confer upon the Grantee any right to be retained by or in the employ or service of the Company and shall not interfere in any way with the right of the Company to terminate the Grantee’s employment or service at any time.  The right of the Company to terminate at will the Grantee’s employment or service at any time for any reason is specifically reserved.

			
	
			
				 11.
			No Shareholder Rights.  Neither the Grantee, nor any person entitled to exercise the Grantee’s rights in the event of the Grantee’s death, shall have any of the rights and privileges of a shareholder with respect to the shares of Company Stock subject to the Option, until certificates for shares of Company Stock have been issued upon the exercise of the Option.

			
	
			
				 12.
			Assignment and Transfers.  Except as the Committee may otherwise permit pursuant to the Plan, the rights and interests of the Grantee under this Agreement may not be sold, assigned, encumbered or otherwise transferred except, in the event of the death of the Grantee, by will or by the laws of descent and distribution.  In the event of any attempt by the Grantee to alienate, assign, pledge, hypothecate, or otherwise dispose of the Option or any right hereunder, except as provided for in this Agreement, or in the event of the levy or any attachment, execution or similar process upon the rights or interests hereby conferred, the Company may terminate the Option by notice to the Grantee, and the Option and all rights hereunder shall thereupon become null and void.  The rights and protections of the Company hereunder shall extend to any successors or assigns of the Company and to the Company’s parents, subsidiaries, and affiliates.  This Agreement may be assigned by the Company without the Grantee’s consent.

		
			

		 

		

			-  4  -

		

 

		

			
	
			
				 13.
			Applicable Law.  The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflicts of laws provisions thereof.

			
	
			
				 14.
			Notice.  Any notice to the Company provided for in this Agreement shall be addressed to the Company, in care of the Committee, and any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll of the Company, or to such other address as the Grantee may designate to the Company in writing.  

		
			 
		

		
			

		 

		

			-  5  -

		

 

		

		
			IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute this Agreement, and the Grantee has executed this Agreement, effective as of the Date of Grant.
		

		
			 
		

		
			Strongbridge Biopharma plc
		

		
			
		

		
			By:
		

		
			Name:
		

		
			Title:
		

		
			 
		

		
			I hereby accept the Option described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement.  I hereby further agree that all the decisions and determinations of the Committee shall be final and binding.
		

		
			 
		

		
			Grantee: 
		

		
			 
		

		
			 
		

		
			Date: 
		

		
			 
		

		
			 
		

		
			 
		

		
			

		 

		

			(Signature Page to Incentive Stock Option Award Agreement)

		

		

			 

		

 

		

		
			ATTACHMENT A
		

		
			 
		

		
			The Option shall become vested and exercisable according to the following vesting schedule, if the Grantee continues to be employed by, or provide service to, the Employer from the Date of Grant until the applicable vesting date:
		

		
			 
		

		
			[VESTING SCHEDULE]
		

		
			 
		

		
			The vesting of the Option shall be cumulative, but shall not exceed 100% of the shares subject to the Option granted above.  If the foregoing schedule would produce fractional shares, the portion of the Option that vests shall be rounded down to the nearest whole share.sbbp_Ex_1017

		
			Exhibit 10.17
		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			2015 EQUITY COMPENSATION PLAN
		

		
			NONQUALIFIED STOCK OPTION AWARD
		

		
			Strongbridge Biopharma plc (the “Company”) has granted you a Nonqualified Stock Option (the “Option”) under the 2015 Equity Compensation Plan (the “Plan”). The terms of the grant are set forth in the Nonqualified Stock Option Award Agreement provided to you (the “Agreement”). The following provides a summary of the key terms of the grant; however, you should read the entire Agreement, along with the terms of the Plan, to fully understand the grant.
		

		
			 
		

		
			SUMMARY OF NONQUALIFIED STOCK OPTION AWARD
		

		
			 
		

		
			Grantee:[NAME]
		

		
			 
		

		
			Date of Grant:_______________
		

		
			 
		

		
			Vesting Schedule:16 equal, quarterly installments following the Grant Date (provided employee is employed by the Company on each vesting date)
		

		
			 
		

		
			Exercise Price Per Share:$_____
		

		
			 
		

		
			Total Number of Options Granted:[#UNITS]
		

		
			 
		

		
			Term/Expiration Date:________________
		

		
			

		 

		

			 

		

		

			 

		

 

		

		
			STRONGBRIDGE BIOPHARMA PLC
		

		
			 
		

		
			2015 EQUITY COMPENSATION PLAN
		

		
			 
		

		
			NONQUALIFIED STOCK OPTION AWARD AGREEMENT
		

		
			 
		

		
			This NONQUALIFIED STOCK OPTION AWARD AGREEMENT (the “Agreement”), dated as of _______________ (the “Date of Grant”), is delivered by Strongbridge Biopharma plc (the “Company”) to [NAME] (the “Grantee”).
		

		
			 
		

		
			RECITALS
		

		
			 
		

		
			A.The 2015 Equity Compensation Plan (the “Plan”) provides for the grant of options to purchase shares of common stock of the Company (“Company Stock”). The Company has decided to make a stock option award as an inducement for the Grantee to promote the best interests of the Company and its stockholders. Capitalized terms that are used but not defined herein shall have the respective meanings accorded to such terms in the Plan.
		

		
			 
		

		
			B.The Plan is administered and interpreted by the Compensation Committee of the Board of Directors of the Company (the “Board”) (or a subcommittee thereof), or such other committee of the Board (including, without limitation, the full Board) to which the Board has delegated power to act under or pursuant to the provisions of the Plan (the “Committee”). The Committee may delegate authority to one or more subcommittees as it deems appropriate. If a subcommittee is appointed, all references in this Agreement to the “Committee” shall be deemed to refer to the committee.
		

		
			NOW, THEREFORE, the parties to this Agreement, intending to be legally bound hereby, agree as follows:
		

		
			1.Grant of Option. Subject to the terms and conditions set forth in this Agreement and in the Plan, the Company hereby grants to the Grantee a Nonqualified Stock Option (the “Option”) to purchase [#UNITS] shares of Company Stock at an exercise price of $_____ per share.
		

		
			 
		

		
			2.Vesting. The Option shall become vested and exercisable, according to the following vesting schedule, if the Grantee continues to be employed by, or provide service to, the Company (or its parent or subsidiary, as applicable) (the “Employer”) from the Date of Grant until the applicable vesting date.
		

		
			 
		

			
					
						Vesting Date

					
					
						% of Option Vested

				
	
					
						16 equal, quarterly installments following the Grant Date (provided employee is employed by the Company on each vesting date)

					
					
						100% of the Option

				

		
			 
		

		
			

		 

		

			-  1  -

		

		

			 

		

 

		

		
			The vesting of the Option shall be cumulative, but shall not exceed 100% of the shares subject to the Option granted above. If the foregoing schedule would produce fractional shares, the portion of the Option that vests shall be rounded down to the nearest whole share.
		

		
			 
		

		
			3.Term of Option.
		

		
			(a)The Option shall have a term of ten (10) years from the Date of Grant and shall terminate at the expiration of that period, unless it is terminated at an earlier date pursuant to the provisions of this Agreement or the Plan.
		

		
			(b)Unless a later termination date is provided for in a Company-sponsored plan, policy or arrangement, or any agreement to which the Employer is a party, the Option shall automatically terminate upon the happening of the first of the following events:
		

		
			(i)The expiration of the ninety (90) day period after the Grantee ceases to be employed by, or provide service to, the Employer, if the termination is for any reason other than Disability (as defined in the Plan), death or Cause (as defined in the Plan).
		

		
			(ii)The expiration of the one (1) year period after the Grantee ceases to be employed by, or provide service to, the Employer on account of the Grantee’s Disability.
		

		
			(iii)The expiration of the one (1) year period after the Grantee ceases to be employed by, or provide service to, the Employer, if the Grantee dies (x) while employed by, or providing service to, the Employer or (y) within ninety (90) days after the Grantee ceases to be so employed or provide such services on account of a termination described in subparagraph (i) above.
		

		
			(iv)The date on which the Grantee ceases to be employed by, or provide service to, the Employer on account of a termination by the Employer for Cause. In addition, notwithstanding the prior provisions of this Paragraph 3, if the Board determines that the Grantee has engaged in conduct that constitutes Cause at any time while the Grantee is employed by, or providing service to, the Employer or after the Grantee’s termination of employment or service, any Option held by the Grantee shall immediately terminate, and the Grantee shall automatically forfeit all shares underlying any exercised portion of an Option for which the Company has not yet delivered the share certificates, upon refund by the Company of the Exercise Price paid by the Grantee for such shares.
		

		
			Notwithstanding the foregoing, in no event may the Option be exercised after the date that is immediately before the tenth anniversary of the Date of Grant. Any portion of the Option that is not vested and exercisable at the time the Grantee ceases to be employed by, or provide service to, the Employer shall immediately terminate.
		

		
			4.Exercise Procedures
		

		
			(a)Subject to the provisions of Paragraphs 2 and 3 above, the Grantee may exercise part or all of the vested Option by delivering a written notice of exercise to the Company in the manner provided in this Agreement, specifying the number of shares of Company Stock as to 

		 

		

			-  2  -

		

		

			 

		

 

which the Option is to be exercised. The Grantee shall pay the Exercise Price (i) in cash, (ii) by delivering shares of Company Stock owned by the Grantee (including Company Stock acquired in connection with the exercise of an Option, subject to such restrictions as the Committee deems appropriate) and having a Fair Market Value on the date of exercise equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares of Company Stock having a Fair Market Value on the date of exercise equal to the Exercise Price; (iii) by payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board; or (iv) by such other method as the Committee may approve. In addition, the Grantee may elect to settle the Option on a “net basis” by taking delivery of the number of Company Stock equal to Fair Market Value of the shares subject to any Option less the exercise price, any tax (or governmental obligation) or other administration fees due. The Company may impose from time to time such limitations as it deems appropriate on the use of shares of Company Stock to exercise the Option.
		

		
			(b)The obligation of the Company to deliver shares of Company Stock upon exercise of the Option shall be subject to all applicable laws, rules, and regulations and such approvals by governmental agencies as may be deemed appropriate by the Company, including such actions as Company counsel shall deem necessary or appropriate to comply with relevant securities laws and regulations. The Company may require that the Grantee (or other person exercising the Option after the Grantee’s death) represent that the Grantee is purchasing shares of Company Stock for the Grantee’s own account and not with a view to or for sale in connection with any distribution of the shares of Company Stock, or such other representation as the Company deems appropriate.
		

		
			(c)All obligations of the Company under this Agreement shall be subject to the rights of the Company as set forth in the Plan to withhold amounts required to be withheld for any taxes, if applicable. The Grantee may elect to satisfy any tax withholding obligation of the Company with respect to the Option by having shares of Company Stock withheld up to an amount that does not exceed the minimum applicable withholding tax rate for federal (including FICA), state and local tax liabilities.
		

		
			5.Change of Control. Upon a Change of Control (as defined in the Plan), the Option shall automatically accelerate and become fully vested and exercisable, provided that the Grantee is employed by, or providing service to, the Employer on the date of such Change of Control.
		

		
			6.Restrictions on Exercise. Except as the Company may otherwise permit pursuant to the Plan, only the Grantee may exercise rights under the Option during the Grantee’s lifetime and, after the Grantee’s death, the Option shall be exercisable (subject to the limitations specified in the Plan) solely by the personal representative or other person entitled to succeed to the rights of the Grantee, or by the person who acquires the right to exercise the Option by will or by the laws of descent and distribution, or if permitted in any case by the Committee, pursuant to a domestic relations order or otherwise as permitted by the Committee, to the extent that the Option is vested and exercisable pursuant to this Agreement. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Option under the Grantee’s will or under the applicable laws of descent and distribution.
		

		
			7.Adjustments. The provisions of the Plan applicable to Adjustments (as described in Section 3 of the Plan) shall apply to the Option.
		

		
			

		 

		

			-  3  -

		

		

			 

		

 

		

		
			8.Grant Subject to Plan Provisions. This grant is made pursuant to the Plan, the terms of which are incorporated herein by reference, and in all respects shall be interpreted in accordance with the Plan. The grant and exercise of the Option are subject to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee in accordance with the provisions of the Plan, including, but not limited to, provisions pertaining to (i) rights and obligations with respect to withholding taxes, (ii) the registration, qualification or listing of the shares of Company Stock, (iii) changes in capitalization of the Company and (iv) other requirements of applicable law. The Committee shall have the authority to interpret and construe the Option pursuant to the terms of the Plan, and its decisions shall be conclusive as to any questions arising hereunder.
		

		
			9.No Employment or Other Rights. The grant of the Option shall not confer upon the Grantee any right to be retained by or in the employ or service of the Company and shall not interfere in any way with the right of the Company to terminate the Grantee’s employment or service at any time. The right of the Company to terminate at will the Grantee’s employment or service at any time for any reason is specifically reserved.
		

		
			10.No Shareholder Rights. Neither the Grantee, nor any person entitled to exercise the Grantee’s rights in the event of the Grantee’s death, shall have any of the rights and privileges of a shareholder with respect to the shares of Company Stock subject to the Option, until certificates for shares of Company Stock have been issued upon the exercise of the Option.
		

		
			11.Assignment and Transfers. Except as the Committee may otherwise permit pursuant to the Plan, the rights and interests of the Grantee under this Agreement may not be sold, assigned, encumbered or otherwise transferred except, in the event of the death of the Grantee, by will or by the laws of descent and distribution or if permitted in any specific case by the Committee, pursuant to a domestic relations order or otherwise as permitted by the Committee. In the event of any attempt by the Grantee to alienate, assign, pledge, hypothecate, or otherwise dispose of the Option or any right hereunder, except as provided for in this Agreement, or in the event of the levy or any attachment, execution or similar process upon the rights or interests hereby conferred, the Company may terminate the Option by notice to the Grantee, and the Option and all rights hereunder shall thereupon become null and void. The rights and protections of the Company hereunder shall extend to any successors or assigns of the Company and to the Company’s parents, subsidiaries, and affiliates. This Agreement may be assigned by the Company without the Grantee’s consent.
		

		
			12.Applicable Law. The validity, construction, interpretation and effect of this Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to the conflicts of laws provisions thereof.
		

		
			13.Notice. Any notice to the Company provided for in this Agreement shall be addressed to the Company in care of the Committee, and any notice to the Grantee shall be addressed to such Grantee at the current address shown on the payroll of the Company, or to such other address as the Grantee may designate to the Company in writing.
		

		
			 
		

		
			

		 

		

			-  4  -

		

		

			 

		

 

		

		
			IN WITNESS WHEREOF, the Company has caused its duly authorized officer to execute this Agreement, and the Grantee has executed this Agreement, effective as of the Date of Grant.
		

		
			Strongbridge Biopharma plc
		

		
			By:______________________________
Name: Matthew Pauls
Title: Chief Executive Officer
		

		
			I hereby accept the Option described in this Agreement, and I agree to be bound by the terms of the Plan and this Agreement. I hereby further agree that all the decisions and determinations of the Committee shall be final and binding.
		

		
			Grantee:
		

		
			 
		

		
			______________________________
Name:  [name]
		

		
			 
		

		
			Date:______________________________
		

		
			 
		

		
			 
		

		
			(Signature Page to Nonqualified Stock Option Award Agreement)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}]]